NO144488C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater

Info

Publication number
NO144488C
NO144488C NO4652/72A NO465272A NO144488C NO 144488 C NO144488 C NO 144488C NO 4652/72 A NO4652/72 A NO 4652/72A NO 465272 A NO465272 A NO 465272A NO 144488 C NO144488 C NO 144488C
Authority
NO
Norway
Prior art keywords
diisoprostanic
preparation
acid derivatives
therapeutic activities
analogy procedure
Prior art date
Application number
NO4652/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO144488B (no
Inventor
Carmelo Gandolfi
Gianfederico Doria
Pietro Gaio
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NO144488B publication Critical patent/NO144488B/no
Publication of NO144488C publication Critical patent/NO144488C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NO4652/72A 1971-12-17 1972-12-15 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater NO144488C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3252071 1971-12-17

Publications (2)

Publication Number Publication Date
NO144488B NO144488B (no) 1981-06-01
NO144488C true NO144488C (no) 1981-09-09

Family

ID=11235473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4652/72A NO144488C (no) 1971-12-17 1972-12-15 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater

Country Status (17)

Country Link
US (1) US4089896A (cs)
JP (1) JPS5747188B2 (cs)
AT (1) AT340607B (cs)
BE (1) BE792803A (cs)
CA (1) CA999857A (cs)
CH (1) CH585197A5 (cs)
CS (1) CS174189B2 (cs)
DE (1) DE2261496A1 (cs)
FR (1) FR2163697B1 (cs)
GB (1) GB1420338A (cs)
HU (1) HU168381B (cs)
IL (1) IL41033A (cs)
NL (1) NL7217104A (cs)
NO (1) NO144488C (cs)
SE (1) SE415095B (cs)
SU (2) SU694069A3 (cs)
ZA (1) ZA728821B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096342A (en) * 1972-09-15 1978-06-20 The Upjohn Company 8β,12α,15β-PGE2 compounds
US3969396A (en) * 1972-09-15 1976-07-13 The Upjohn Company 8β, 11β, 12α-PGE2 compounds
US3975426A (en) * 1972-09-15 1976-08-17 The Upjohn Company 8β, 11β, 12α-PGF2.sub.β -compounds
DE2460285A1 (de) * 1973-12-25 1975-07-03 Ono Pharmaceutical Co Trans-delta hoch 2-prostaglandinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE4024345A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100355A (en) * 1972-09-15 1978-07-11 The Upjohn Company 8β,12α-PGE2 -type compounds

Also Published As

Publication number Publication date
GB1420338A (en) 1976-01-07
IL41033A0 (en) 1973-02-28
NL7217104A (cs) 1973-06-19
JPS5747188B2 (cs) 1982-10-07
FR2163697B1 (cs) 1978-02-10
AT340607B (de) 1977-12-27
NO144488B (no) 1981-06-01
FR2163697A1 (cs) 1973-07-27
DE2261496A1 (de) 1973-06-20
ATA1070872A (de) 1977-04-15
US4089896A (en) 1978-05-16
BE792803A (fr) 1973-03-30
IL41033A (en) 1977-10-31
SU626692A3 (ru) 1978-09-30
SU694069A3 (ru) 1979-10-25
SE415095B (sv) 1980-09-08
ZA728821B (en) 1973-09-26
CA999857A (en) 1976-11-16
JPS4867257A (cs) 1973-09-13
CS174189B2 (cs) 1977-03-31
CH585197A5 (cs) 1977-02-28
HU168381B (en) 1976-04-28

Similar Documents

Publication Publication Date Title
SE385585B (sv) Forfarande for framstellning av 1-alkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat
SE395890B (sv) Forfarande for framstellning av anthelmintiskt verksamma 2-karbalkoxiamino-bensimidazol-5 (6)-fenyletrar
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
SE409708B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE397973B (sv) Forfarande for framstellning av bensoylfenylsmorsyraderivat
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE380527B (sv) Forfarande for framstellning av 1oh-tieno(3,2-c)(1)-bensazepinderivat
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
NO137093C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
NO143845C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-amino-pyrrolderivater
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
FI55836C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma 4-amino-3-benzylidenhydrazino-1,2,4-triazoler